Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 267

1.
2.

Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults.

Walsh EE, Falsey AR.

J Infect Dis. 2004 Jul 15;190(2):373-8. Epub 2004 Jun 18.

PMID:
15216475
3.

Comparison of respiratory syncytial virus humoral immunity and response to infection in young and elderly adults.

Falsey AR, Walsh EE, Looney RJ, Kolassa JE, Formica MA, Criddle MC, Hall WJ.

J Med Virol. 1999 Oct;59(2):221-6.

PMID:
10459160
6.
7.

Prevalence of respiratory syncytial virus IgG antibodies in infants living in a rural area of Mozambique.

Roca A, Abacassamo F, Loscertales MP, Quintó L, Gómez-Olivé X, Fenwick F, Saiz JC, Toms G, Alonso PL.

J Med Virol. 2002 Aug;67(4):616-23.

PMID:
12116014
8.

Humoral immunity to respiratory syncytial virus in young and elderly adults.

Terrosi C, Di Genova G, Martorelli B, Valentini M, Cusi MG.

Epidemiol Infect. 2009 Dec;137(12):1684-6. doi: 10.1017/S0950268809002593. Epub 2009 Apr 15.

PMID:
19366492
9.

Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine.

Murphy BR, Prince GA, Walsh EE, Kim HW, Parrott RH, Hemming VG, Rodriguez WJ, Chanock RM.

J Clin Microbiol. 1986 Aug;24(2):197-202.

10.

Respiratory syncytial virus infection in older persons.

Falsey AR.

Vaccine. 1998 Nov;16(18):1775-8. Review.

PMID:
9778756
11.

Respiratory syncytial virus specific serum antibodies in infants under six months of age: limited serological response upon infection.

Brandenburg AH, Groen J, van Steensel-Moll HA, Claas EC, Rothbarth PH, Neijens HJ, Osterhaus AD.

J Med Virol. 1997 May;52(1):97-104.

PMID:
9131465
12.

Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis.

Piedra PA, Grace S, Jewell A, Spinelli S, Bunting D, Hogerman DA, Malinoski F, Hiatt PW.

Pediatr Infect Dis J. 1996 Jan;15(1):23-31.

PMID:
8684872
13.

Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin.

Siber GR, Leombruno D, Leszczynski J, McIver J, Bodkin D, Gonin R, Thompson CM, Walsh EE, Piedra PA, Hemming VG, et al.

J Infect Dis. 1994 Jun;169(6):1368-73.

PMID:
8195619
14.
15.

Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults.

Gonzalez IM, Karron RA, Eichelberger M, Walsh EE, Delagarza VW, Bennett R, Chanock RM, Murphy BR, Clements-Mann ML, Falsey AR.

Vaccine. 2000 Mar 6;18(17):1763-72.

PMID:
10699324
16.

Sequential annual administration of purified fusion protein vaccine against respiratory syncytial virus in children with cystic fibrosis.

Piedra PA, Grace S, Jewell A, Spinelli S, Hogerman DA, Malinoski F, Hiatt PW.

Pediatr Infect Dis J. 1998 Mar;17(3):217-24.

PMID:
9535249
17.
18.

The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease.

Eick A, Karron R, Shaw J, Thumar B, Reid R, Santosham M, O'Brien KL.

Pediatr Infect Dis J. 2008 Mar;27(3):207-12. doi: 10.1097/INF.0b013e31815ac585.

PMID:
18277934
19.

Role of neutralizing antibodies in adults with community-acquired pneumonia by respiratory syncytial virus.

Luchsinger V, Piedra PA, Ruiz M, Zunino E, Martínez MA, Machado C, Fasce R, Ulloa MT, Fink MC, Lara P, Avendaño LF.

Clin Infect Dis. 2012 Apr;54(7):905-12. doi: 10.1093/cid/cir955. Epub 2012 Jan 11.

PMID:
22238168
20.

Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.

Li X, Sambhara S, Li CX, Ettorre L, Switzer I, Cates G, James O, Parrington M, Oomen R, Du RP, Klein M.

Virology. 2000 Mar 30;269(1):54-65.

Supplemental Content

Support Center